← back to search

Nicole Baldwin

Palo Alto University · US
Area of research
Pharmacology · Molecular Medicine
Research interest
Research interests include Immunology, Biology, Medicine, Coaching, CDKN2A, and Blockade.
h-index
citations
650
works
8
NIH funding
primary concept
email

Recent publications

mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
Nature Communications 2022cited by 39position: middledoi
Peer support and whole health coaching to address the healthcare needs of homeless veterans: a pilot study
BMC Primary Care 2022cited by 9position: middledoi
Peer Support and Whole Health Coaching to Address the Healthcare Needs of Homeless Veterans: A Pilot Study
Research Square 2022cited by 0position: middledoi
Molecular determinants of response to PD-L1 blockade across tumor types
Nature Communications 2021cited by 169position: middledoi
Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data
Nature Communications 2021cited by 75position: middledoi
Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases
Nature Communications 2019cited by 80position: middledoi
Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses
Science Immunology 2017cited by 165position: middledoi
Multicenter Systems Analysis of Human Blood Reveals Immature Neutrophils in Males and During Pregnancy
The Journal of Immunology 2017cited by 113position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Justeen Hyde · Boston University2 papers (2022–2022)David Smelson · University of Massachusetts Chan Medical School2 papers (2022–2022)D. Keith McInnes · Boston University2 papers (2022–2022)Daniel M. Blonigen · Palo Alto University2 papers (2022–2022) · 2 papers (2022–2022)Ivan Raikov · Stanford University2 papers (2022–2022)Jennifer S. Smith · University of Canberra2 papers (2022–2022)Ethan S. Sokol · Foundation Medicine (United States)1 papers (2021–2021)Namrata S. Patil · Gene Therapy Laboratory1 papers (2021–2021)Yudong Liu · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2017–2017)Edward E. Kadel · Gene Therapy Laboratory1 papers (2021–2021)Edward A. Ganio · Palo Alto University1 papers (2017–2017)Ira Mellman · Amgen (United States)1 papers (2021–2021)Gabriela K. Fragiadakis · University of California, San Francisco1 papers (2017–2017)Christopher R. Bolen · Institute of Infection and Immunity1 papers (2017–2017) · 1 papers (2017–2017)Jana Blažková · National Institutes of Health1 papers (2017–2017)Thomas Powles · St Bartholomew's Hospital1 papers (2021–2021)David K. Stevenson · Stanford University1 papers (2017–2017)Priti S. Hegde · Foundation Medicine (United States)1 papers (2021–2021)